Lily Q. Li

873 total citations
4 papers, 68 citations indexed

About

Lily Q. Li is a scholar working on Psychiatry and Mental health, Cell Biology and Surgery. According to data from OpenAlex, Lily Q. Li has authored 4 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Psychiatry and Mental health, 2 papers in Cell Biology and 1 paper in Surgery. Recurrent topics in Lily Q. Li's work include Migraine and Headache Studies (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper) and Pathogenesis and Treatment of Hiccups (1 paper). Lily Q. Li is often cited by papers focused on Migraine and Headache Studies (3 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper) and Pathogenesis and Treatment of Hiccups (1 paper). Lily Q. Li collaborates with scholars based in United States, Germany and Spain. Lily Q. Li's co-authors include Holland C. Detke, David Doležil, Uwe Reuter, Patricia Pozo‐Rosich, Sheena K. Aurora, Shufang Wang, Shufang Wang, Montaser Shaheen, Eric H. Westin and Aimee Bence Lin and has published in prestigious journals such as Neurology, Cancer Chemotherapy and Pharmacology and Current Medical Research and Opinion.

In The Last Decade

Lily Q. Li

4 papers receiving 68 citations

Peers

Countries citing papers authored by Lily Q. Li

Since Specialization

Citations

This map shows the geographic impact of Lily Q. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Q. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Q. Li more than expected).

Fields of papers citing papers by Lily Q. Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily Q. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Q. Li. The network helps show where Lily Q. Li may publish in the future.

Co-authorship network of co-authors of Lily Q. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lily Q. Li. A scholar is included among the top collaborators of Lily Q. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily Q. Li. Lily Q. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

#	Work	Indexed citations
1	Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) 2022 ·Clinical Drug Investigation ·Stewart J. Tepper, Jessica Ailani, Janet H. Ford, Russell Nichols, Lily Q. Li, (unknown), (unknown), Antje Tockhorn‐Heidenreich	5
2	Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study 2022 ·Current Medical Research and Opinion ·Patricia Pozo‐Rosich, Holland C. Detke, Shufang Wang, David Doležil, Lily Q. Li, Sheena K. Aurora, Uwe Reuter	22
3	One-Year Treatment with Galcanezumab in Patients with Chronic Migraine: Results from the Open-Label Phase of the REGAIN Study (P2.10-010) 2019 ·Neurology ·Holland C. Detke, Patricia Pozo‐Rosich, Uwe Reuter, David Doležil, Lily Q. Li, Shufang Wang, Sheena K. Aurora	12
4	Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer 2017 ·Cancer Chemotherapy and Pharmacology ·Jeffrey R. Infante, Amita Patnaik, Claire F. Verschraegen, Anthony J. Olszanski, Montaser Shaheen, Howard A. Burris, Anthony W. Tolcher, Kyriakos P. Papadopoulos, Muralidhar Beeram, Scott M. Hynes, Jennifer Leohr, Aimee Bence Lin, Lily Q. Li, Anna McGlothlin, Daphne L. Farrington, Eric H. Westin, Roger B. Cohen	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact